Medicare Enrolled
Dr. Michael Dovnarsky, M.D., F.C.C.P.
Cardiovascular Disease · Vineland, NJ
Practice pattern: Cardiac & Cardiac
— Practice combining cardiac and cardiac services
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dovnarsky from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dovnarsky?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dovnarsky
Dr. Michael Dovnarsky is a cardiovascular disease specialist in Vineland, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dovnarsky performed 2,641 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Dovnarsky received a total of $10,771 from 52 pharmaceutical and/or device companies across 562 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dovnarsky is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ 2,641 Medicare services
$10,771 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,641
Medicare services
Bottom 46% in NJ for cardiovascular disease
Not available
Unique patients (not deduplicated)
$91
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
444 | $89 | $250 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
342 | $144 | $604 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
253 | $12 | $46 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
236 | $6 | $50 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
168 | $155 | $494 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
141 | $32 | $80 |
| Heart muscle strain imaging | 134 | $32 | $194 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
106 | $76 | $173 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
92 | $142 | $435 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
90 | $40 | $100 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
89 | $59 | $242 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
87 | $40 | $100 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
82 | $49 | $350 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
80 | $64 | $125 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
72 | $49 | $65 |
| Ultrasound of leg arteries at rest and after exercise This test uses sound waves to create images of the blood vessels in the legs while the patient is resting and after physical activity to assess blood flow. |
50 | $125 | $450 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
36 | $204 | $512 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
35 | $108 | $225 |
| Exercise or drug-induced heart stress test with ECG A test that monitors the heart's electrical activity while the patient exercises or receives medication to increase heart rate. |
18 | $31 | $143 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
18 | $12 | $69 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
16 | $2,143 | $4,900 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 16 | $666 | $1,100 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
14 | $136 | $321 |
| Electrocardiogram, 1-3 leads with physician review A heart rhythm test using one to three electrodes to record electrical activity, with interpretation by a physician. |
11 | $11 | $35 |
| Autonomic nervous system testing with tilt This test evaluates the function of the sympathetic and parasympathetic nervous systems. It involves monitoring the patient for at least five minutes while they are tilted. |
11 | $131 | $330 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
16.4% high complexity
25.9% medium
57.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,771
Total received (2018-2024)
Avg $1,539/year across 7 years
Top 19% in NJ for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
562
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$19
2023
$1,021
2022
$2,064
2021
$2,203
2020
$1,451
2019
$2,049
2018
$1,964
Payments by company (2024)
ABBVIE INC.
$19
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$1,377
Janssen Pharmaceuticals, Inc
$1,273
PFIZER INC.
$800
E.R. Squibb & Sons, L.L.C.
$659
Novartis Pharmaceuticals Corporation
$641
AstraZeneca Pharmaceuticals LP
$593
Amgen Inc.
$545
Philips Electronics North America Corporation
$398
Amarin Pharma Inc.
$309
Novo Nordisk Inc
$296
Boehringer Ingelheim Pharmaceuticals, Inc.
$287
SANOFI-AVENTIS U.S. LLC
$287
Merck Sharp & Dohme LLC
$286
GlaxoSmithKline, LLC.
$269
W. L. Gore & Associates, Inc.
$262
Daiichi Sankyo Inc.
$213
AbbVie Inc.
$208
Lilly USA, LLC
$207
Medtronic Vascular, Inc.
$196
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$193
Merck Sharp & Dohme Corporation
$143
Boston Scientific Corporation
$127
Biohaven Pharmaceutical Holding Company Ltd.
$125
Takeda Pharmaceuticals U.S.A., Inc.
$105
ARBOR PHARMACEUTICALS, INC.
$102
ABBVIE INC.
$89
Lundbeck LLC
$80
Esperion Therapeutics, Inc.
$67
Vanda Pharmaceuticals Inc.
$54
Kowa Pharmaceuticals America, Inc.
$52
Lexicon Pharmaceuticals, Inc.
$45
Circassia Pharmaceuticals Inc
$43
SUN PHARMACEUTICAL INDUSTRIES INC.
$40
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$29
Mannkind Corporation
$29
ARALEZ PHARMACEUTICALS US INC.
$27
Optos, Inc.
$27
Preventice Services, LLC
$26
Arbor Pharmaceuticals, Inc.
$26
Eisai Inc.
$26
Medtronic, Inc.
$26
Genentech USA, Inc.
$25
Dexcom, Inc.
$23
Sun Pharmaceutical Industries Inc.
$22
Ultragenyx Pharmaceutical Inc.
$19
iRhythm Technologies, Inc.
$17
Janssen Biotech, Inc.
$15
IDORSIA PHARMACEUTICALS US INC
$14
Teleflex LLC
$14
Teva Pharmaceuticals USA, Inc.
$13
Biohaven Pharmaceuticals, Inc.
$12
Regeneron Healthcare Solutions, Inc.
$12
Top 3 companies account for 32.0% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (5050) Ext Holter · (5050) Extended Holter · AFREZZA · Aimovig · AirDuo Digihaler · Allure CRT Pacemaker · Allure Quadra RF CRT Pacemaker · Assurity Pacemaker · Azure · BELSOMRA · BREO · BRILINTA · CAMZYOS · CARDIOFORM Septal Occluder · CHANTIX · CREON · CRT-Ds · CRYSVITA · Confirm Rx · Corlanor · Dayvigo · Dexcom G6 Transmitter · Durata Defibrillation ICD Lead · ELIQUIS · EMBLEM · EMGALITY · ENTRESTO · EZALLOR SPRINKLE · Edarbi · Edarbyclor · Ellipse ICD · Enbrel · FARXIGA · FASENRA · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fortify Assura · FreeStyle Libre 2 · GORE CARDIOFORM Septal Occluder · HETLIOZ · Hetlioz · Horizant · INJECTAFER · InPen · Inpefa · JANUVIA · JARDIANCE · KAPSPARGO · LEQVIO · LOKELMA · LifeVest · Livalo · MOUNJARO · MULTAQ · NEXLETOL · NURTEC ODT · Nanostim Leadleas Pacemaker · Ozempic · P200DTx · PRADAXA · PRALUENT · PREVNAR 20 · QULIPTA · QUVIVIQ · Quadra Allure MP RF CRT Pacemkr · REXULTI · Repatha · SHINGRIX · SIMPONI ARIA · SOLIQUA · SOLIQUA 100/33 · STIOLTO RESPIMAT · Saxenda · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TUDORZA PRESSAIR · Thoratec n CentriMag n PediMag · UBRELVY · UROLIFT · VERQUVO · VRAYLAR · Vascepa · Wegovy · XARELTO · XIFAXAN · Xofluza · ZIO Patch · ZONTIVITY
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
75
County median income
$64,499
Nearest hospital to ZIP centroid (approximate)
INSPIRA MEDICAL CENTER VINELAND
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dovnarsky is a cardiac & cardiac specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dovnarsky experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Dovnarsky performed 444 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Dovnarsky receive payments from pharmaceutical companies?
Yes. Dr. Dovnarsky received a total of $10,771 from 52 companies across 562 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dovnarsky's costs compare to other cardiologists in Vineland?
Dr. Dovnarsky's average Medicare payment per service is $91. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dovnarsky) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Vineland
Browse cardiologists in Vineland ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NJ
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NJ
Which NJ cardiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology